Healthcare > Medical Devices & Equipment
•1105 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (1105)
| Company | Market Cap | Price |
|---|---|---|
|
BLFS
BioLife Solutions, Inc.
Sells consumables such as hPL, CellSeal vials, and CryoCase used within CGT workflows.
|
$1.28B |
$26.70
-1.07%
|
|
AMPH
Amphastar Pharmaceuticals, Inc.
Inhalation systems and advanced formulations imply medical device components bridging drug delivery.
|
$1.27B |
$27.35
-1.23%
|
|
CTS
CTS Corporation
CTS targets medical end-markets with diagnostic/sensor applications; tagged under Medical Devices & Biometrics.
|
$1.26B |
$42.58
+0.15%
|
|
SSII
SS Innovations International, Inc.
Core product: robotic surgical system and endo-surgical instruments (SSi Mantra and related tools) sold as surgical equipment.
|
$1.24B |
$6.02
-0.66%
|
|
IRMD
IRadimed Corporation
IRADIMED's core offerings are MRI-compatible medical devices (infusion pumps and monitoring systems), which fall under Medical Devices & Biometrics.
|
$1.18B |
$92.78
+0.60%
|
|
TIC
TIC Solutions, Inc.
Laboratory Testing & Advisory Services aligns with Acuren's lab-based destructive testing capabilities and analytical advisory work.
|
$1.17B |
$9.52
-1.04%
|
|
XERS
Xeris Biopharma Holdings, Inc.
Prefillable Syringes describe a major packaging format used for injectable drugs in Xeris's portfolio.
|
$1.16B |
$7.18
+1.20%
|
|
CSTL
Castle Biosciences, Inc.
Provides laboratory-based molecular diagnostic testing and related advisory services directly to clinicians.
|
$1.16B |
$39.98
+0.13%
|
|
NNE
Nano Nuclear Energy Inc
Company engages in laboratory testing/advisory services related to nuclear tech development and regulatory readiness.
|
$1.16B |
$30.84
+1.92%
|
|
UCTT
Ultra Clean Holdings, Inc.
Provides laboratory testing and advisory services relevant to semiconductor manufacturing cleanliness and optimization.
|
$1.14B |
$25.15
+1.00%
|
|
THRM
Gentherm Incorporated
Medical devices & biometrics including patient temperature management devices.
|
$1.09B |
$35.67
-1.08%
|
|
INMD
InMode Ltd.
InMode's core business is medical devices and biometrics, with RF-based aesthetic platforms and related systems.
|
$1.08B |
$14.06
-0.50%
|
|
PCRX
Pacira BioSciences, Inc.
IOvera is a medical device product, placing Pacira in the Medical Devices & Biometrics category.
|
$1.07B |
$23.82
+2.78%
|
|
OPK
OPKO Health, Inc.
OPKO's BioReference segment provides laboratory testing and advisory services.
|
$1.06B |
$1.35
|
|
IART
Integra LifeSciences Holdings Corporation
Wound care/regenerative product portfolio (IDRT, PriMatrix, SurgiMend, DuraSorb, MediHoney) constitutes major product lines.
|
$1.02B |
$13.11
-1.06%
|
|
EYPT
EyePoint Pharmaceuticals, Inc.
Implantable ophthalmic device component due to bioerodible Durasert E delivery system.
|
$1.02B |
$14.78
+0.24%
|
|
MDXG
MiMedx Group, Inc.
Directly manufactures and sells wound care devices and placental tissue allografts (EPIFIX, EPICORD, EPIEFFECT) used in wound healing.
|
$1.02B |
$6.89
-0.86%
|
|
PSNL
Personalis, Inc.
NeXT Personal is a tumor-informed liquid biopsy-based MRD test, central to PSNL's offerings.
|
$950.62M |
$10.71
-4.46%
|
|
CDNA
CareDx, Inc
Directly provides Laboratory Testing & Advisory Services through its testing portfolio and diagnostic operations.
|
$947.97M |
$17.81
-0.50%
|
|
SPRY
ARS Pharmaceuticals, Inc.
Neffy includes a needle-free delivery device, aligning with Medical Devices & Biometrics.
|
$945.77M |
$9.57
+3.18%
|
|
MRVI
Maravai LifeSciences Holdings, Inc.
Biologics safety testing kits and related analytical services (e.g., residual DNA quantification, Protein L assays) are direct BST offerings.
|
$929.52M |
$3.65
-2.93%
|
|
PLSE
Pulse Biosciences, Inc.
Pulse Biosciences develops nsPFA-based medical devices (e.g., CellFX platform) for non-thermal tissue ablation across soft tissue and cardiac indications.
|
$927.77M |
$13.80
+3.53%
|
|
FLGT
Fulgent Genetics, Inc.
Laboratory testing and advisory services.
|
$922.86M |
$30.16
-2.25%
|
|
ALNT
Allient Inc.
Medical Device Components align with Allient’s product capabilities used in medical device applications.
|
$917.51M |
$54.05
+1.37%
|
|
MEG
Montrose Environmental Group, Inc.
Laboratory testing and advisory services as part of Montrose's measurement and analysis offerings.
|
$905.10M |
$25.66
+0.25%
|
|
SIBN
SI-BONE, Inc.
SI-BONE operates as a medical device company that designs, develops and sells orthopedic implants and related medical devices.
|
$840.39M |
$19.49
-0.92%
|
|
BFLY
Butterfly Network, Inc.
Core ultrasound imaging hardware and point-of-care devices (POCUS) produced by Butterfly.
|
$775.36M |
$3.08
-9.29%
|
|
MATW
Matthews International Corporation
Memorialization segment includes embalming chemicals and funeral supplies (memorialization products).
|
$767.31M |
$24.93
-1.01%
|
|
EMBC
Embecta Corp.
Embecta operates as a medical device company focused on insulin injection devices, including pen needles, syringes, and safety products.
|
$735.16M |
$12.62
-7.11%
|
|
CRMD
CorMedix Inc.
DefenCath is an FDA-approved antimicrobial catheter-lock device marketed by CorMedix.
|
$720.36M |
$9.65
+2.66%
|
|
PACB
Pacific Biosciences of California, Inc.
PacBio directly manufactures diagnostic sequencing equipment (instruments) used in molecular diagnostics and research laboratories.
|
$717.89M |
$2.39
-9.13%
|
|
CTKB
Cytek Biosciences, Inc.
Cytek's instrument manufacturing includes flow cytometry diagnostic equipment, the core product line referenced in the article.
|
$712.45M |
$5.62
-3.52%
|
|
MYGN
Myriad Genetics, Inc.
Laboratory testing and advisory services; Myriad operates clinical labs delivering diagnostic tests.
|
$707.14M |
$7.61
-3.79%
|
|
CLB
Core Laboratories N.V.
CLB provides laboratory testing and advisory services via proprietary tracers and reservoir analysis capabilities.
|
$701.06M |
$14.96
-0.50%
|
|
KE
Kimball Electronics, Inc.
KE's medical device and biometrics manufacturing capabilities are central to its strategy.
|
$698.95M |
$28.90
+1.16%
|
|
ORGO
Organogenesis Holdings Inc.
Core wound care device category covering Apligraf and Dermagraft, along with barrier products like PuraPly and FortiShield.
|
$687.57M |
$5.43
+2.84%
|
|
OFIX
Orthofix Medical Inc.
Core product category covering orthopedic implants and surgical devices, including spinal hardware.
|
$637.44M |
$16.11
-0.12%
|
|
BVS
Bioventus Inc.
Bioventus designs and manufactures medical devices and biometrics solutions for musculoskeletal health.
|
$632.49M |
$7.65
-1.80%
|
|
NUTX
Nutex Health, Inc.
Nutex Health operates micro-hospitals and provides hospital services including acute inpatient care and emergency/observation services.
|
$627.81M |
$112.63
-5.52%
|
|
CBLL
CeriBell, Inc.
Ceribell's core product is a point-of-care diagnostic EEG system (diagnostic equipment).
|
$619.99M |
$16.89
-2.65%
|
|
SRDX
Surmodics, Inc.
Surmodics' vascular intervention devices (SurVeil DCB, Pounce thrombectomy, Sublime radial access) are a core product category sold by the company.
|
$614.58M |
$42.98
|
|
TCMD
Tactile Systems Technology, Inc.
Core medical devices for lymphedema and airway clearance (Flexitouch Plus, Nimbl, AffloVest) are manufactured and sold by the company.
|
$578.04M |
$25.93
-0.52%
|
|
AVNS
Avanos Medical, Inc.
The RFA portfolio (ESENTEC, TRIDENT, COOLIEF) places Avanos in the neuromodulation devices category.
|
$549.41M |
$11.86
-0.96%
|
|
LAB
Standard BioTools Inc.
SomaScan laboratory testing and advisory services are a core direct offering.
|
$546.25M |
$1.43
+0.35%
|
|
NPCE
NeuroPace, Inc.
Core product Neuromodulation device (RNS System) delivering brain-responsive, on-demand therapy for drug-resistant epilepsy.
|
$545.84M |
$16.53
-1.02%
|
Showing page 5 of 12 (1105 total stocks)
Loading company comparison...
Loading industry trends...
Loading research report...
